» Articles » PMID: 36367104

TSG-6 (Tumor Necrosis Factor-α-Stimulated Gene/Protein-6): An Emerging Remedy for Renal Inflammation

Overview
Journal Hypertension
Date 2022 Nov 11
PMID 36367104
Authors
Affiliations
Soon will be listed here.
Abstract

The inflammatory response is a major pathological feature in most kidney diseases and often evokes compensatory mechanisms. Recent evidence suggests that TSG-6 (tumor necrosis factor-α-stimulated gene/protein-6) plays a pivotal role in anti-inflammation in various renal diseases, including immune-mediated and nonimmune-mediated renal diseases. TSG-6 has a diverse repertoire of anti-inflammatory functions: it potentiates antiplasmin activity of IαI (inter-α-inhibitor) by binding to its light chain, crosslinks hyaluronan to promote its binding to cell surface receptor CD44, and thereby regulate the migration and adhesion of lymphocytes, inhibits chemokine-stimulated transendothelial migration of neutrophils by directly interacting with the glycosaminoglycan binding site of CXCL8 (CXC motif chemokine ligand-8), and upregulates COX-2 (cyclooxygenase-2) to produce anti-inflammatory metabolites. Hopefully, further developments can target this anti-inflammatory molecule to the kidney and harness its remedial properties. This review provides an overview of the emerging role of TSG-6 in blunting renal inflammation.

Citing Articles

The Role of Cytokines and Chemokines as Biomarkers of Disease Activity in Idiopathic Nephrotic Syndrome in Children.

Kopac M, Jerin A, Petrera A, Osredkar J Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996798 PMC: 11854277. DOI: 10.3390/cimb47020077.


A diagnostic signatures for intervertebral disc degeneration using TNFAIP6 and COL6A2 based on single-cell RNA-seq and bulk RNA-seq analyses.

Song H, Li Z, Huang Q, Wu C, Li M, Shen J Ann Med. 2024; 57(1):2443568.

PMID: 39704340 PMC: 11703038. DOI: 10.1080/07853890.2024.2443568.


Identification of TNFAIP6 as a reliable prognostic indicator of low-grade glioma.

Huang Q, Liang H, Shi S, Ke Y, Wang J Heliyon. 2024; 10(12):e33030.

PMID: 38948040 PMC: 11211890. DOI: 10.1016/j.heliyon.2024.e33030.


TGF-β1 induces formation of TSG-6-enriched extracellular vesicles in fibroblasts which can prevent myofibroblast transformation by modulating Erk1/2 phosphorylation.

Ilg M, Bustin S, Ralph D, Cellek S Sci Rep. 2024; 14(1):12389.

PMID: 38811625 PMC: 11136978. DOI: 10.1038/s41598-024-62123-x.


Mesenchymal Stromal Cells: New Generation Treatment of Inflammatory Bowel Disease.

Wei S, Li M, Wang Q, Zhao Y, Du F, Chen Y J Inflamm Res. 2024; 17:3307-3334.

PMID: 38800593 PMC: 11128225. DOI: 10.2147/JIR.S458103.


References
1.
Chen C . COX-2's new role in inflammation. Nat Chem Biol. 2010; 6(6):401-2. DOI: 10.1038/nchembio.375. View

2.
Balakumar P, Sambathkumar R, Mahadevan N, Bin Muhsinah A, Alsayari A, Venkateswaramurthy N . A potential role of the renin-angiotensin-aldosterone system in epithelial-to-mesenchymal transition-induced renal abnormalities: Mechanisms and therapeutic implications. Pharmacol Res. 2019; 146:104314. DOI: 10.1016/j.phrs.2019.104314. View

3.
Maruyama T, Fukuda N, Matsumoto T, Kano K, Endo M, Kazama M . Systematic implantation of dedifferentiated fat cells ameliorated monoclonal antibody 1-22-3-induced glomerulonephritis by immunosuppression with increases in TNF-stimulated gene 6. Stem Cell Res Ther. 2015; 6:80. PMC: 4455708. DOI: 10.1186/s13287-015-0069-2. View

4.
Rabieian R, Boshtam M, Zareei M, Kouhpayeh S, Masoudifar A, Mirzaei H . Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis. J Cell Biochem. 2017; 119(1):17-27. DOI: 10.1002/jcb.26146. View

5.
Dyer D, Thomson J, Hermant A, Jowitt T, Handel T, Proudfoot A . TSG-6 inhibits neutrophil migration via direct interaction with the chemokine CXCL8. J Immunol. 2014; 192(5):2177-85. PMC: 3988464. DOI: 10.4049/jimmunol.1300194. View